Fortis Group Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.3K Hold
50
﹤0.01% 463
2026
Q1
$4.52K Hold
50
﹤0.01% 442
2025
Q4
$4.5K Hold
50
﹤0.01% 441
2025
Q3
$4.92K Hold
50
﹤0.01% 394
2025
Q2
$4.56K Hold
50
﹤0.01% 395
2025
Q1
$5.66K Hold
50
﹤0.01% 346
2024
Q4
$5.28K Hold
50
﹤0.01% 360
2024
Q3
$5.4K Hold
50
﹤0.01% 351
2024
Q2
$5.43K Hold
50
﹤0.01% 346
2024
Q1
$6.6K Sell
50
-50
-50% -$6.25K ﹤0.01% 352
2023
Q4
$12.2K Buy
100
+50
+100% +$5.58K ﹤0.01% 279
2023
Q3
$5.61K Buy
+50
New +$6.35K ﹤0.01% 278
2020
Q3
$6K Buy
+52
New +$6.79K ﹤0.01% 330

Other funds holding ZBH

Fortis Group Advisors's ZBH Position: Q2 2026 in Review

Fortis Group Advisors held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 50 shares worth $4.3K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Fortis Group Advisors first reported a position in ZBH in Q3 2020 and has held it in 13 quarters since. The position peaked at $12.2K in Q4 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Fortis Group Advisors held 50 shares of Zimmer Biomet worth $4.3K as of Q2 2026.
  • Fortis Group Advisors left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Fortis Group Advisors's portfolio in Q2 2026, its #463 holding.
  • Fortis Group Advisors first reported a position in Zimmer Biomet in Q3 2020 and has held it in 13 quarters since.
  • Fortis Group Advisors's Zimmer Biomet position peaked at $12.2K in Q4 2023.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.